Securing a CDMO with Pharmatech Associates (a CPhI WW preview)
Update: 2022-09-12
Description
Bikash Chatterjee and Stephanie Gaulding, CEO and MD at drug development consultancy firm Pharmatech Associates, talk about the different partnering and outsourcing strategies innovators can take, with a specific focus on smaller and mid-sized biotechs, which often don’t have the same level of in-built CMC expertise as Big Pharma. Whether you go with a single end-to-end CDMO or a multi-model approach, one thing is clear: know your product, know your needs and plan early.
This conversation originally took place as a Linkedin Live event ahead of the CPhI Worldwide conference happening in Frankfurt in November.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
